Sapacitabine shows 35% improved patients
Hi all,
Now results from the Sapacitabine Phase II study - 61 patients - have been reported. The 7-day high dose schedule got the best result with 35 % improved patients. http://production.investis.com/cyc/i...10/2010-06-07/ Kind regards Birgitta-A |
All times are GMT -4. The time now is 01:46 PM. |
Powered by vBulletin® Version 3.6.7
Copyright ©2000 - 2024, Jelsoft Enterprises Ltd.
Forum sites may contain non-authoritative and unverified information.
Medical decisions should be made in consultation with qualified medical professionals.
Site contents exclusive of member posts Copyright © 2006-2020 Marrowforums.org